Thromboelastometric detection of clotting factor XIII deficiency in cardiac surgery patients

Transfusion Medicine

Volumn 23, Issue 6, 2013, Pages 407-415

  Grossmann, E ^a   Akyol, D ^b   Eder, L ^a   Hofmann, B ^c   Haneya, A ^b   Graf, B M ^b   Bucher, M ^a   Raspe C ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cardiac surgery; Coagulation; Extracorporeal circulation; Factor XIII; ROTEM

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 CONCENTRATE; FIBRINOGEN; TRANEXAMIC ACID;

ABLATION THERAPY; ADULT; AGED; AORTA SURGERY; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING PARAMETERS; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC TEST; ELECTIVE SURGERY; EXTRACORPOREAL CIRCULATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART SURGERY; HEART VALVE SURGERY; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; MALE; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; POINT OF CARE TESTING; POSTOPERATIVE PERIOD; ROTATIONAL THROMBOELASTOMETRY; SURGICAL PATIENT; THROMBOCYTE COUNT;

CARDIAC SURGERY; COAGULATION; EXTRACORPOREAL CIRCULATION; FACTOR XIII; ROTEM;

AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; EXTRACORPOREAL CIRCULATION; FACTOR VIII; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; THROMBELASTOGRAPHY;

EID: 84888339199     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/tme.12069     Document Type: Article

References (48)

1. Abels, J., Smit Sibinga, C.T. & Meyler, L. (1970) Congenital hemorrhagic diathesis with deficiency of Factor XIII. A case report and a family study. Thrombosis et Diathesis Haemorrhagica, 23, 340-346.
2. Abramson, D.C., Abouleish, E.I. & Pivalizza, E.G. (1996) Heparinase-guided thrombelastography in an anticoagulated patient. British Journal of Anaesthesia, 77, 556-558.
3. Attie-Castro, F.A., Zago, M.A., Rodriguez-Delfin, L., Guerreiro, J.F. & Franco, R.F. (2000) Ethnic heterogeneity of the Factor XIII Val34Leu polymorphism. Thrombosis and Haemostasis, 84, 601-603.
4. Birnbaum, D. & Betz, P. (1990) Die extrakorporale Zirkulation als Risikofaktor der Herzchirurgie. Zeitschrift für Kardiologie, 79 (Suppl. 4), 87-93.
5. Broessner, G. & Lackner, P. (2009) Red blood cell transfusion and mortality. Critical Care Medicine, 37, 2997.
6. Calatzis, A., Gödje, O., Haas, S., Fuchs, A. & Reichart, B. (1999) Erhöhung der Gerinnselfestigkeit vor und nach herzchirurgischen Eingriffen durch Zusatz von Faktor XIII in vitro. In: Klinische Aspekte des Faktor-XIII Mangels. Diagnostik, klinische Relevanz, klinische Forschung (eds Egbring, R., Seitz, R. & Wozniak, R.), 55-62. Karger, Basel.
7. Caprini, J.A., Arcelus, J.I. & Goldshteyn, S. (1995) Thromboelastography: measuring statistical probabilities. Seminars in Thrombosis and Hemostasis, 21 (Suppl 4), 14-20.
8. Chandler, W.L. (1995) The thromboelastograph and the thromboelastograph technique. Seminars in Thrombosis and Hemostasis, 21 (Suppl. 4), 1-6.
9. Chandler, W.L., Patel, M.A. & Gravelle, L. (2001) Factor XIIIA and clot strength after cardiopulmonary bypass. Blood Coagulation & Fibrinolysis, 12, 101-108.
10. De Nicola, P. & Spreafico, P.L. (1966) Studies on the evaluation of Factor XIII (fibrin stabilizing factor) by means of the MIA tolerance (visual and thrombelastographic technique). Hémostase, 6, 325-332.
11. DeAnda, A. Jr., Baker, K.M., Roseff, S.D., Green, J.A., McCarthy, H., Aron, T. & Spiess, B.D. (2006) Developing a blood conservation program in cardiac surgery. American Journal of Medical Quality, 21, 230-237.
12. Fenzel, T., Sibrowski, W. & Westphal, M. (2008) Red-cell storage and complications of cardiac sugery. The New England Journal of Medicine, 358, 2841.
13. Francis, J.L. (1980) The detection and measurement of Factor XIII activity: a review. Journal of Medical Laboratory Science, 37, 137-147.
14. German Medical Association. Cross-sectional Guidelines for Therapy with Blood Components and Plasma Derivatives. www.bundesaerztekammer.de/downloads/LeitCrossBloodComponents4ed.pdf, 2008.
15. Goedje, O., Haushofer, M. & Lamm, P. (1998) The effect of Factor XIII on bleeding in coronary surgery. The Journal of Thoracic and Cardiovascular Surgery, 46, 263-267.
16. Goedje, O., Gallmeier, U. & Schelian, M. (2006) Coagulation Factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. The Journal of Thoracic and Cardiovascular Surgery, 54, 26-33.
17. Goerlinger, K. (2006) Coagulation management during liver transplantation. Hämostaseologie, 26 (3 Suppl. 1), 64-76.
18. Greenberg, C.S., Achyuthan, K.E. & Fenton, J.W. (1987) Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma Factor XIII. Blood, 69, 867-871.
19. Greilich, P.E., Brouse, C.F., Beckham, J., Jessen, M.E., Martin, E.J. & Carr, M.E. (2002) Reductions in platelet contractile force correlate with duration of cardiopulmonary bypass and blood loss in patients undergoing cardiac surgery. Thrombosis Research, 105, 523-529.
20. Hartert, H. (1948) Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klinische Wochenschrift, 26, 577-583.
21. Heymann, C., Redlich, U., Moritz, M., Sander, M., Vargas, H.O., Grubitzsch, H., Konertz, W.F. & Spies, C. (2005) Aspirin and clopidogrel taken until 2 days prior to coronary artery bypass graft surgery is associated with increased postoperative drainage loss. The Journal of Thoracic and Cardiovascular Surgery, 53, 341-345.
22. Jambor, C., Reul, V. & Schnider, T.W. (2009) In vitro inhibition of Factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood. Anesthesia and Analgesia, 109, 1023-1028.
23. Karkouti, K., O'Farrell, R. & Yau, T.M. (2006) Reducing Bleeding in Cardiac Surgery Research Group. Prediction of massive blood transfusion in cardiac surgery. Canadian Journal of Anaesthesiology, 53, 781-794.
24. Kettner, S.C., Panzer, O.P. & Kozek, S.A. (1999) Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Anesthesia and Analgesia, 89, 580-584.
25. Kobbervig, C. & Williams, E. (2004) FXIII polymorphisms, fibrin clot structure and thrombotic risk. Biophysical Chemistry, 112, 223-228.
26. Kohler, H.P., Ariëns, R.A., Whitaker, P. & Grant, P.J. (1998) A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thrombosis and Haemostasis, 80, 704.
27. Lang, T. & Depka, M. (2006) Possibilities and limitations of thrombelastometry/-graphy. Hämostaseologie, 26, 20-29.
28. Lang, T., Toller, W. & Gutl, M. (2004) Different effects of abciximab and cytochalasin D on clot strength in thrombelastography. Journal of Thrombosis and Haemostasis, 2, 147-153.
29. Luddington, R.J. (2005) Thrombelastography/thromboelastometry. Clinical and Laboratory Haematology, 27, 81-90.
30. Mahla, E., Lang, T. & Vicenzi, M.N. (2001) Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesthesia and Analgesia, 92, 572-577.
31. McDonagh, J., McDonagh, R.P., Delage, J.M. & Wagner, R.H. (1969) Factor XIII in human plasma and platelets. The Journal of Clinical Investigation, 48, 940-946.
32. Mittermayr, M., Margreiter, J. & Velik-Salchner, C. (2005) Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem): an in vitro study. British Journal of Anaesthesia, 95, 310-316.
33. Nielsen, V.G., Geary, B.T. & Baird, M.S. (2000) Evaluation of the contribution of platelets to clot strength by thromboelastography in rabbits: the role of tissue factor and cytochalasin D. Anesthesia and Analgesia, 91, 35-39.
34. Nielsen, V.G., Gurley, W.Q. & Burch, T.M. (2004) The impact of Factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesthesia and Analgesia, 99, 120-123.
35. Paparella, D., Brister, S.J. & Buchanan, M.R. (2004) Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Medicine, 30, 1873-1881.
36. Pisano, J.J., Finlayson, J.S. & Peyton, M.P. (1968) Cross-link in fibrin polymerized by Factor 13: epsilon-(gamma-glutamyl)lysine. Science, 160, 892-893.
37. Salooja, N. & Perry, D.J. (2001) Thrombelastography. Blood Coagulation & Fibrinolysis, 12, 327-337.
38. Schroeder, V., Chatterjee, T. & Kohler, H.P. (2001) Influence of blood coagulation Factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography. Thrombosis Research, 104, 467-474.
39. Schwarzt, M.L. & Pizzo, S.V. (1973) Human Factor XIII from plasma and platelets. The Journal of Biological Chemistry, 248, 1395-1407.
40. Spiess, B.D., Wall, M.H. & Gillies, B.S. (1997) A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass. Thrombosis and Haemostasis, 78, 820-826.
41. Theusinger, O.M., Baulig, W., Asmis, L.M., Seifert, B. & Spahn, D.R. (2010) In vitro Factor XIII supplementation increases clot firmness in rotation thrombelastometry (ROTEM). Thrombosis and Haemostasis, 104, 385-391.
42. Tyler, H.M. (1969) Fibrin crosslinking demonstrated by thrombelastography. Thrombosis et Diathesis Haemorrhagica, 22, 398-400.
43. Wahba, A., Rothe, G., Lodes, H., Barlage, S. & Schmitz, G. (2001) The influence of the duration of cardiopulmonary bypass on coagulation and platelet function. The Journal of Thoracic and Cardiovascular Surgery, 49, 153-156.
44. Weber, C.F., Jambor, C., Marquardt, M. & Zwissler, B. (2008) Erfassung eines Faktor XIII Mangels mit der Thrombelastometrie. Anaesthesist, 57, 487-490.
45. Wenker, O., Wojciechowski, Z., Sheinbaum, R. & Zisman, E. (1997) Thrombelastography. The Internet Journal of Anesthesiology. Vol. 1; 1-6. URL http://www.ispub.com/journals/IJA/Vol1N3/teg.htm.
46. Wettstein, P., Haeberli, A. & Stutz, M. (2004) Decreased Factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesthesia and Analgesia, 99, 1564-1569.
47. Williams, J.B., Philips-Bute, B., Bhattacharya, S.D., Lima, B., Smith, P.K., Hughes, G.C. & Welsby, I.J. (2011) Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest. The Journal of Thoracic and Cardiovascular Surgery, 141, 1283-1288.
48. Wippermann, J., Albes, J.M. & Hartrumpf, M. (2005) Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system. European Journal of Cardiothoracic Surgery, 28, 127-132.